Form 6-K GLAXOSMITHKLINE PLC For: Sep 29
FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
Report of Foreign
Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For
period ending 29 September 2016
GlaxoSmithKline plc
(Name
of registrant)
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or
will
file annual reports under cover Form 20-F or Form 40-F
Form
20-F x Form 40-F
--
Indicate
by check mark whether the registrant by furnishing the
information
contained in this Form is also thereby furnishing the
information
to the Commission pursuant to Rule 12g3-2(b) under the
Securities
Exchange Act of 1934.
Yes
No x
GlaxoSmithKline
plc (the 'Company')
Transaction
notification
1.
|
Details
of PDMR/person closely associated with them ('PCA')
|
||
a)
|
Name
|
Dr K
Slaoui
|
|
b)
|
Position/status
|
PCA of
Dr M M Slaoui (Chairman, Global Vaccines)
|
|
c)
|
Initial notification/
amendment
|
Initial
notification
|
|
2.
|
Details
of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
|
||
a)
|
Name
|
GlaxoSmithKline
plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details
of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transaction(s) has been
conducted
|
||
a)
|
Description of the
financial instrument
|
GlaxoSmithKline
plc American Depositary Shares ('ADSs')
ISIN:
US37733W1053
|
|
b)
|
Nature
of the transaction
|
Award
of ADSs under the Company's 2009 Share Value Plan
|
|
c)
|
Price(s) and
volume(s)
|
Price(s)
|
Volume(s)
|
$43.58
|
2,300
|
||
d)
|
Aggregated information
Aggregated volume Price
|
n/a
(single transaction)
|
|
e)
|
Date
of the
transaction
|
2016-09-22
|
|
f)
|
Place
of the transaction
|
n/a
|
1.
|
Details
of PDMR/person closely associated with them ('PCA')
|
||
a)
|
Name
|
Mrs V A
Whyte
|
|
b)
|
Position/status
|
Company
Secretary
|
|
c)
|
Initial notification/
amendment
|
Initial
notification
|
|
2.
|
Details
of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
|
||
a)
|
Name
|
GlaxoSmithKline
plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details
of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transaction(s) has been
conducted
|
||
a)
|
Description of the
financial instrument
|
Ordinary
shares of 25 pence each 'Ordinary Shares'
ISIN:
GB0009252882
|
|
b)
|
Nature
of the transaction
|
Award
of Ordinary Shares under the Company's 2009 Share Value
Plan
|
|
c)
|
Price(s) and
volume(s)
|
Price(s)
|
Volume(s)
|
£16.49
|
11,060
|
||
d)
|
Aggregated
information
Aggregated
volume Price
|
n/a
(single transaction)
|
|
e)
|
Date
of the
transaction
|
2016-09-22
|
|
f)
|
Place
of the transaction
|
n/a
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorised.
GlaxoSmithKline plc
(Registrant)
Date: September
29, 2016
By: VICTORIA
WHYTE
----------------------
Victoria Whyte
Authorised
Signatory for and on
behalf
of GlaxoSmithKline plc
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GSK (GSK) call put ratio 12 calls to 1 put with focus on April weekly (26) 41 calls
- Yalla Group Releases 2023 ESG Report
- Virtu Announces First Quarter 2024 Results
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!